IRCT2016081525949N3已完成2 期
Effect of coenzyme Q10 supplementation on serum adiponectin-to-leptin ratio, 8-isoprostane and malondialdehyde in female patients with type 2 diabetes
Vice Chancellor for research of Arak University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 65 years（—）
- 性别
- Female
入选标准
- •Patients that have been suffered type 2 diabetes for more than 2 years and that have not consumed vitamin and mineral supplements during the last three months. Exclusion criteria: changing in dosage of glucose lowering medications, physical activity and diet during the intervention; any chronic renal, hepatic, thyroid, haematic and gastrointestinal disorders; hormone therapy; insulin therapy; alcoholism; smoking; pregnancy; lactation and using anticoagulants, diuretics and ß blockers.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Effect of coenzyme Q10 supplementation on some biochemical factors in 2 diabetesType 2 diabetic.Non-insulin-dependent diabetes mellitusIRCT2016011325949N2Vice Chancellor for research of Arak University of Medical Sciences68
已完成
不适用
The effect of Q10 on breast cancer treatmentIRCT2015042021874N1Vice Chancellor for research of Ahvaz University of Medical Sciences60
已完成
2 期
The effect of coenzyme Q10 on serum concentrations of adipokines and Malondialdehyde in non-alcoholic fatty liver diseaseon-alcoholic fatty liver disease.Other diseases of liverIRCT201206094105N8Vice chancellor for Research, Tabriz University of Medical Sciences44
已完成
2 期
The Effect of coenzyme Q10 on serum concentrations of pentraxin 3 and metabolic parameters in non-alcoholic fatty liver diseaseon-alcoholic fatty liver disease.Other diseases of liverIRCT201305254105N12Vice chancellor for Research, Tabriz University of Medical Sciences44
已完成
2 期
Benefits of Q10 supplementation in patients with type II diabetesIRCT2016011125949N1Vice Chancellor for research of Arak University of Medical Sciences70